Loading: 100%
ATHENAHEALTH INC logo
no logo available
General Information
Investor relations pageIR page no data available
Founding year no data available
Headquarter , , no data available
Employees 5,305 (as per Q2 2017)no data available
Sector Application Software, TechnologyApplication Software, Technologyno data available
Ticker ATHNno data available
Financial year endsFY ends End of Decemberno data available
Stock Information (historical prices adjusted for splits and dividends)
Adj. Closing prices (in USD) -Common sharesNov. 16Jan. 17März 17Mai 17Juli 17Sep. 1780100120140160
datesClosing price (adj.)
13.10.2017115.42
11.10.2017120.47
04.10.2017120.56
27.09.2017123.28
20.09.2017123.91
13.09.2017130.98
06.09.2017139.67
30.08.2017140.35
23.08.2017139.13
16.08.2017144.18
09.08.2017141.09
02.08.2017145.40
26.07.2017145.75
19.07.2017143.38
12.07.2017140.36
05.07.2017140.24
27.06.2017142.03
20.06.2017144.58
13.06.2017141.35
06.06.2017137.81
30.05.2017135.42
23.05.2017132.06
16.05.2017109.75
09.05.2017107.93
02.05.2017100.63
25.04.2017119.63
18.04.2017112.31
11.04.2017114.93
04.04.2017112.61
28.03.2017111.77
21.03.2017111.76
14.03.2017113.24
07.03.2017115.01
28.02.2017117.93
21.02.2017118.42
14.02.2017114.83
07.02.2017111.22
31.01.2017125.99
24.01.2017122.46
17.01.2017120.67
10.01.2017118.17
03.01.2017108.55
27.12.2016107.16
19.12.2016114.37
12.12.201696.95
05.12.201697.22
28.11.2016100.17
21.11.2016101.89
14.11.2016101.81
07.11.2016103.53
31.10.2016103.32
24.10.2016112.96
17.10.2016123.50
no share price data source found
Share price data requested
Key Figures
Last Closing Price
as per Oct 13, 2017, in USD
115.42n/a
Market Capitalisation
in million USD
4,609n/a
Enterprise Value
in million USD
4,818n/a
Common Shares Outstanding
as per Jul 17, 2017
39,929,842n/a
Preferred Shares Outstanding
as per Jul 17, 2017
n/a
Average Basic Shares Outstanding
TTM
39,575,000n/a
Average Diluted Shares Outstanding
TTM
40,725,000n/a
Index Membership
n/a
Business Summary
athenahealth Inc provides healthcare IT services through cloud-based and mobile application products. Their services include revenue cycle and practice management, electronic health records, patient engagement, and clinical decision support.
no data available
Key Financials & Ratios (all figures TTM as per , million USD, full statements further below)
Profit & Loss
Revenues 0n/a
Gross Profit 0n/a
Operating Income 0n/a
EBITDA 0n/a
Net Profit 0n/a
Balance Sheet
Cash and Cash Equivalents 71n/a
Receivables 170n/a
Total Current Assets 288n/a
PP&E 363n/a
Total Assets 1,244n/a
Accounts Payable 6n/a
Current Debt 16n/a
Total Current Liabilities 177n/a
Long-Term Debt 264n/a
Total Liabilities 527n/a
Total Equity 717n/a
Cash Flow
Depreciation & Amortisation 149n/a
Change in Working Capital -60n/a
Operating Cash Flow 169n/a
Net Change in PP&E and Intangibles -86n/a
Investing Cash Flow -224n/a
Dividends Paid 0n/a
Financing Cash Flow -8n/a
Total Change in Cash -63n/a
Free Cash Flow 0n/a
Profitability Ratios
Gross Margin 0.0%n/a
Operating Margin 0.0%n/a
Net Profit Margin 0.0%n/a
Return on Equity 0.0%n/a
Return on Assets 0.0%n/a
Per Share Figures
Basic EPS n/a
Diluted EPS n/a
Sales per Share n/a
Book Value per Share 18.12n/a
FCF per Share n/a
Dividends per Share 0.00n/a
Price Multiples
Price to Earnings Ratio n/a
Price to Sales Ratio n/a
Price to Book Value 6.37n/a
Price to Free Cash Flow n/a
Valuation Metrics
EV/EBITDA n/a
EV/Sales n/a
Book to Market Value 0.16n/a
Other Ratios
Current Ratio 162.5%n/a
Liabilities to Equity Ratio 73.5%n/a
Debt to Assets Ratio 22.5%n/a
Profit & Loss StatementP&L data quality: 12% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '08FY '09FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Revenue
273
189
246
324
422
595
753
925
1,083
Sales & Services Revenue
0
0
0
0
0
0
0
0
0
Financing Revenue
0
0
0
0
0
0
0
0
0
Other Revenue
0
0
0
0
0
0
0
0
0
Cost of revenue
-60
-79
-97
-123
-167
-239
-369
-462
-534
Cost of Goods & Services
0
0
0
0
0
0
0
0
0
Cost of Financing Revenue
0
0
0
0
0
0
0
0
0
Cost of Other Revenue
0
0
0
0
0
0
0
0
0
Gross Profit
213
110
149
201
255
356
384
463
549
Other Operating Income
0
0
0
0
0
0
0
0
0
Operating Expenses
-69
-92
-125
-169
-221
-350
-383
-467
-523
Selling, General & Administrative
-52
-70
-96
-128
-161
-249
-300
-356
-388
Selling & Marketing
0
0
0
0
0
0
0
0
0
General & Administrative
0
0
0
0
0
0
0
0
0
Research & Development
-11
-14
-18
-23
-34
-58
-83
-111
-135
Depreciation & Amortization
-6
-8
-11
-17
-26
-44
0
0
0
Provision For Doubtful Accounts
0
0
0
0
0
0
0
0
0
Other Operating Expense
0
0
0
0
0
0
0
0
0
Operating Income (Loss)
144
17
24
33
35
6
1
-4
27
Non-Operating Income (Loss)
-2
-1
0
1
1
4
5
34
6
Interest Expense, net
-2
-1
0
0
0
4
5
6
6
Interest Expense
0
0
0
0
0
0
0
0
0
Interest Income
0
0
0
0
0
0
0
0
0
Other Investment Income (Loss)
0
0
0
0
0
0
0
0
0
Foreign Exchange Gain (Loss)
0
0
0
0
0
0
0
0
0
Income (Loss) from Affiliates
0
0
0
0
0
0
0
0
0
Other Non-Operating Income (Loss)
0
0
0
0
1
0
0
29
0
Pretax Income (Loss), Adjusted
142
16
23
34
36
10
6
30
33
Abnormal Gains (Losses)
1
-1
0
0
0
0
0
0
0
Acquired In-Process R&D
0
0
0
0
0
0
0
0
0
Merger / Acquisition Expense
0
0
0
0
0
0
0
0
0
Abnormal Derivatives
0
0
0
0
0
0
0
0
0
Disposal of Assets
0
0
0
0
0
0
0
0
0
Early extinguishment of Debt
0
0
0
0
0
0
0
0
0
Asset Write-Down
0
0
0
0
0
0
0
0
0
Impairment of Goodwill & Intangibles
0
0
0
0
0
0
0
0
0
Sale of Business
0
0
0
0
0
0
0
0
0
Legal Settlement
0
0
0
0
0
0
0
0
0
Restructuring Charges
0
0
0
0
0
0
0
0
0
Sale of and Unrealized Investments
0
0
0
0
0
0
0
0
0
Insurance Settlement
0
0
0
0
0
0
0
0
0
Other Abnormal Items
0
0
0
0
0
0
0
0
0
Pretax Income (Loss)
143
16
23
34
36
10
6
30
33
Income Tax (Expense) Benefit, net
23
-9
-10
-14
-16
0
1
-5
0
Current Income Tax
0
0
0
0
0
0
0
0
0
Deferred Income Tax
0
0
0
0
0
0
0
0
0
Tax Allowance/Credit
0
0
0
0
0
0
0
0
0
Income (Loss) from Affiliates, net of taxes
0
0
0
0
0
0
0
0
0
Income (Loss) from Continuing Operations
166
7
13
20
20
10
6
25
33
Net Extraordinary Gains (Losses)
0
0
0
0
0
0
0
0
0
Discontinued Operations
0
0
0
0
0
0
0
0
0
XO & Accounting Charges & Other
0
0
0
0
0
0
0
0
0
Income (Loss) Including Minority Interest
166
7
13
20
20
10
6
25
33
Minority Interest
0
0
0
0
0
0
0
0
0
Net Income
166
7
13
20
20
10
6
25
33
Preferred Dividends
0
0
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
0
0
Net Income Available to Common Shareholders
166
7
13
20
20
10
6
25
33
Remarks
restated on Feb 18, 2011 n/a
calculated values,
restated on Feb 16, 2012 n/a
calculated values,
restated on Feb 11, 2013 n/a
calculated values,
restated on Feb 7, 2014 n/a
calculated values,
restated on Feb 9, 2015 n/a
calculated values,
restated on Feb 4, 2016 n/a
calculated values,
restated on Feb 2, 2017 n/a
calculated values,
restated on Feb 2, 2017 n/a
calculated values,
restated on Feb 2, 2017 n/a
calculated values,
Balance SheetBS data quality: 60% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '08FY '09FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Assets
Cash, Cash Equivalents & Short Term Investments
n/a
83
116
120
193
65
115
142
147
Cash & Cash Equivalents
n/a
31
36
58
155
65
74
142
147
Short Term Investments
n/a
52
80
62
38
0
41
0
0
Accounts & Notes Receivable
n/a
33
37
49
62
87
122
148
162
Accounts Receivable, Net
n/a
33
37
49
62
87
122
148
162
Notes Receivable, Net
n/a
0
0
0
0
0
0
0
0
Unbilled Revenues
n/a
0
0
0
0
0
0
0
0
Inventories
n/a
0
0
0
0
0
0
0
0
Raw Materials
n/a
0
0
0
0
0
0
0
0
Work In Process
n/a
0
0
0
0
0
0
0
0
Finished Goods
n/a
0
0
0
0
0
0
0
0
Other Inventory
n/a
0
0
0
0
0
0
0
0
Other Short Term Assets
n/a
5
7
9
12
20
22
30
34
Prepaid Expenses
n/a
5
7
9
11
17
22
30
34
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
0
0
Assets Held-for-Sale
n/a
0
0
0
0
0
0
0
0
Deferred Tax Assets
n/a
0
0
0
0
0
0
0
0
Income Taxes Receivable
n/a
0
0
0
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
0
0
0
Miscellaneous Short Term Assets
n/a
0
0
0
1
3
0
0
0
Total Current Assets
n/a
121
160
178
267
173
259
320
343
Property, Plant & Equipment, Net
n/a
25
32
52
54
213
272
322
348
Property, Plant & Equipment
n/a
0
0
0
0
0
0
0
0
Accumulated Depreciation
n/a
0
0
0
0
0
0
0
0
Long Term Investments & Receivables
n/a
1
7
22
3
8
6
14
18
Long Term Investments
n/a
0
0
0
0
0
0
0
0
Long Term Marketable Securities
n/a
0
0
0
0
0
0
0
0
Long Term Receivables
n/a
0
0
0
0
0
0
0
0
Other Long Term Assets
n/a
54
51
85
93
403
394
463
481
Intangible Assets
n/a
17
16
27
38
198
196
234
238
Goodwill
n/a
22
22
47
48
198
198
229
241
Other Intangible Assets
n/a
0
0
0
0
0
0
0
0
Prepaid Expense
n/a
0
0
0
0
0
0
0
0
Deferred Tax Assets
n/a
6
4
5
7
6
0
0
2
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
0
0
Prepaid Pension Costs
n/a
0
0
0
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
0
0
0
Investments in Affiliates
n/a
0
0
0
0
0
0
0
0
Miscellaneous Long Term Assets
n/a
9
9
5
0
0
0
0
0
Total Noncurrent Assets
n/a
80
90
158
149
624
672
798
846
Total Assets
n/a
201
250
336
417
796
931
1,119
1,189
Liabilities and owners' equity
Payables & Accruals
n/a
28 28435000
31 30718000
52 52268000
58 57809000
73 72754000
118 118211000
150 150300000
151 150900000
Accounts Payable
n/a
2 1880000
1 559000
6 6318000
2 1733000
4 3930000
9 9410000
11 10800000
10 9500000
Accrued Taxes
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Interest & Dividends Payable
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Payables & Accruals
n/a
27 26555000
30 30159000
46 45950000
56 56076000
69 68824000
109 108801000
140 139500000
141 141400000
Short Term Debt
n/a
5 4725000
4 4406000
1 960000
1 799000
15 15000000
15 14550000
11 10800000
18 18300000
Short Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Short Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Current Portion of Long Term Debt
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Short Term Liabilities
n/a
15 14613000
16 16427000
19 18877000
20 19968000
62 62002000
72 72398000
33 32600000
29 28700000
Deferred Revenue
n/a
4 4038000
5 4978000
6 6345000
8 8209000
27 27002000
29 28949000
33 32600000
29 28700000
Derivatives & Hedging
n/a
0 291000
0 490000
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
10 10284000
11 10959000
13 12532000
12 11759000
0 0
8 8449000
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Short Term Liabilities
n/a
0 0
0 0
0 0
0 0
35 35000000
35 35000000
0 0
0 0
Total Current Liabilities
n/a
48 47773000
52 51551000
72 72105000
79 78576000
150 149756000
205 205159000
194 193700000
198 197900000
Long Term Debt
n/a
9 8951000
6 6307000
0 0
0 0
174 173750000
158 157822000
287 287400000
273 272800000
Long Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Long Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Long Term Liabilities
n/a
37 37319000
44 43518000
53 52742000
50 49987000
82 81582000
93 92516000
94 94300000
85 85200000
Accrued Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Pension Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Pensions
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Post-Retirement Benefits
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Compensation
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Revenue
n/a
29 28684000
36 35661000
44 44281000
46 45515000
53 53172000
54 54473000
56 55900000
48 48400000
Deferred Tax Liabilities
n/a
0 0
0 0
0 0
0 0
21 21421000
10 10417000
1 1300000
0 0
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Long Term Liabilities
n/a
9 8635000
8 7857000
8 8461000
4 4472000
7 6989000
28 27626000
37 37100000
37 36800000
Total Noncurrent Liabilities
n/a
46 46270000
50 49825000
53 52742000
50 49987000
255 255332000
250 250338000
382 381700000
358 358000000
Total Liabilities
n/a
94 94043000
101 101376000
125 124847000
129 128563000
405 405088000
455 455497000
575 575400000
556 555900000
Preferred Equity
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Share Capital & Additional Paid-In Capital
n/a
170 170067000
201 200697000
247 247498000
304 303923000
381 381354000
444 443654000
523 522800000
592 591900000
Common Stock
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Additional Paid in Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Share Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Treasury Stock
n/a
-1 -1200000
-1 -1200000
-1 -1200000
-1 -1200000
-1 -1200000
-1 -1200000
-1 -1200000
-1 -1200000
Retained Earnings
n/a
-41 -41476000
-29 -28772000
-10 -9726000
9 9006000
12 11600000
8 8481000
23 22500000
44 43500000
Other Equity
n/a
0 -73000
0 28000
0 -101000
0 -81000
0 -446000
24 24188000
-1 -800000
-1 -900000
Equity Before Minority Interest
n/a
127 127318000
171 170753000
236 236471000
312 311648000
391 391308000
475 475123000
543 543300000
633 633300000
Minority Interest
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Total Equity
n/a
127 127318000
171 170753000
236 236471000
312 311648000
391 391308000
475 475123000
543 543300000
633 633300000
Total Liabilities & Equity
n/a
221 221361000
272 272129000
361 361318000
440 440211000
796 796396000
931 930620000
1,119 1118700000
1,189 1189200000
Remarks restated on n/a restated on Feb 18, 2011 n/a restated on Feb 16, 2012 n/a restated on Feb 11, 2013 n/a restated on Feb 7, 2014 n/a restated on Feb 9, 2015 n/a restated on Feb 4, 2016 n/a restated on Feb 2, 2017 n/a restated on Jul 20, 2017 n/a
Cash Flow StatementCF data quality: 97% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '08FY '09FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Net Income/Starting Line
32
9
13
19
19
3
-3
14
21
Net Income
0
0
0
0
0
0
0
0
0
Net Income From Discontinued Operations
0
0
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
0
0
Depreciation & Amortization
6
8
13
19
29
62
94
118
143
Non-Cash Items
-18
12
9
5
8
29
34
14
47
Stock-Based Compensation
0
0
0
0
0
0
0
0
0
Deferred Income Taxes
0
0
0
0
0
0
0
0
0
Other Non-Cash Adjustments
0
0
0
0
0
0
0
0
0
Change in Working Capital
2
2
10
18
14
0
25
18
-28
(Increase) Decrease in Accounts Receivable
0
0
0
0
0
0
0
0
0
(Increase) Decrease in Inventories
0
0
0
0
0
0
0
0
0
Increase (Decrease) in Accounts Payable
0
0
0
0
0
0
0
0
0
Increase (Decrease) in Other
0
0
0
0
0
0
0
0
0
Net Cash From Discontinued Operations (operating)
0
0
0
0
0
0
0
0
0
Cash from Operating Activities
21
32
45
61
70
93
149
164
183
Change in Fixed Assets & Intangibles
-13
-10
-16
-17
-24
-38
-76
-87
-69
Disposition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
0
Disposition of Fixed Assets
0
0
0
0
0
0
0
0
0
Disposition of Intangible Assets
0
0
0
0
0
0
0
0
0
Acquisition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
0
Purchase of Fixed Assets
0
0
0
0
0
0
0
0
0
Acquisition of Intangible Assets
0
0
0
0
0
0
0
0
0
Other Change in Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
0
Net Change in Long Term Investment
-57
5
-35
2
41
56
0
30
0
Decrease in Long Term Investment
0
0
0
0
0
0
0
0
0
Increase in Long Term Investment
0
0
0
0
0
0
0
0
0
Net Cash From Acquisitions & Divestitures
-7
-22
0
-35
-6
-410
0
-40
-17
Net Cash from Divestitures
0
0
0
0
0
0
0
0
0
Cash for Acqusition of Subsidiaries
0
0
0
0
0
0
0
0
0
Cash for Joint Ventures
0
0
0
0
0
0
0
0
0
Net Cash from Other Acquisitions
0
0
0
0
0
0
0
0
0
Other Investing Activities
2
-5
-3
-4
-12
-33
-51
-102
-89
Net Cash From Discontinued Operations (investing)
0
0
0
0
0
0
0
0
0
Cash from Investing Activities
-75
-33
-54
-53
0
-425
-127
-199
-175
Dividends Paid
0
0
0
0
0
0
0
0
0
Cash From (Repayment of) Debt
5
-3
-4
-1
0
235
0
265
0
Cash From (Repayment of) Short Term Debt, net
0
0
0
0
0
0
0
0
0
Cash From (Repayment of) Long Term Debt, net
0
0
0
0
0
0
0
0
0
Repayments of Long Term Debt
0
0
0
0
0
0
0
0
0
Cash From Long Term Debt
0
0
0
0
0
0
0
0
0
Cash From (Repurchase of) Equity
5
3
9
14
19
31
21
22
16
Increase in Capital Stock
5
3
9
14
19
31
21
22
16
Decrease in Capital Stock
0
0
0
0
0
0
0
0
0
Other Financing Activities
0
3
9
1
8
-24
-34
-183
-18
Net Cash From Discontinued Operations (financing)
0
0
0
0
0
0
0
0
0
Cash from Financing Activities
11
3
14
14
27
242
-13
104
-2
Net Cash Before Disc. Operations and FX
-43
2
5
22
97
-90
9
69
6
Change in Cash from Disc. Operations and Other
0
0
0
0
0
0
0
0
0
Net Cash Before FX
-43
2
5
22
97
-90
9
69
6
Effect of Foreign Exchange Rates
0
0
0
0
0
0
0
0
0
Net Changes in Cash
-43
2
5
22
97
-90
9
68
6
Remarks
restated on Feb 18, 2011 n/a
calculated values,
restated on Feb 16, 2012 n/a
calculated values,
restated on Feb 11, 2013 n/a
calculated values,
restated on Feb 7, 2014 n/a
calculated values,
restated on Feb 9, 2015 n/a
calculated values,
restated on Feb 4, 2016 n/a
calculated values,
restated on Feb 2, 2017 n/a
calculated values,
restated on Feb 2, 2017 n/a
calculated values,
restated on Feb 2, 2017 n/a
calculated values,
Some of the data shown on this page is provided for free by IEX
Sumo